Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian stock market firm on global cues
Tue, 28 Jun 09:30 am

Asian stock markets have opened the day on a firm note. Stock markets in South Korea (up 1%), Indonesia (up 0.1%), Hong Kong (up 0.4%) and Japan (up 1%) are trading in the green while China (down 0.3%) is trading in the red. The Indian stock markets have opened the day on a firm note. Stocks in the metals and capital goods space are leading the gains. However, oil & gas and FMCG stocks are trading in the red.

The BSE-Sensex is trading up by 90 points (0.5%) and the NSE-Nifty is up by around 28 points (0.5%). Midcap and small cap stocks are trading in the green, with the BSE Midcap and BSE Small cap indices up by 0.4% and 0.5% respectively. The rupee is trading at 45.03 to the US dollar.

Pharma stocks have opened the day on a firm note with Lupin and Cipla trading in the green. Drug maker, Glenmark Pharma received the approval from the US authorities for its US$ 613 m out-licensing deal with Sanofi. With respect to it, Glenmark also received an upfront payment of US$ 25 m from Sanofi. The deal was finalized last month through its South African subsidiary. As per the deal the company was out-licence its novel molecule named 'GBR 500' to Sanofi. The molecule is aimed for treating disease related to digestive system disorders. As per the deal, exclusive marketing rights for developed countries for products developed using this molecule are given to Sanofi.

Software stocks have opened the day on a firm note with Tech Mahindra and HCL Tech trading in the green. Tech Mahindra announced that the headquarters for its business process outsourcing (BPO) business will be Nigeria. It further expressed its intention of scaling up the African operations. The company is focusing on the growing market of Africa. Tech Mahindra has recruited more than thousand local employees in African nation. The company plans to nurture talent from local areas for effective BPO operations. Over the last two years, Tech Mahindra has formed partnerships with many companies in the telecom sector like MTN and Multilinks in Nigeria.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian stock market firm on global cues". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.